Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Barbara Garofalo is active.

Publication


Featured researches published by Barbara Garofalo.


Molecular Pharmaceutics | 2009

Novel locally active estrogens accelerate cutaneous wound healing. A preliminary study.

Mario Brufani; Francesca Ceccacci; Luigi Filocamo; Barbara Garofalo; Roberta Joudioux; Angela La Bella; Francesca Leonelli; Luisa Maria Migneco; Rinaldo Marini Bettolo; Paolo Maria Farina; Gillian S. Ashcroft; Claire Routley; Matthew J. Hardman; Clara Meda; Gianpaolo Rando; Adriana Maggi

New 17beta-estradiol (E2) derivatives 1-11 were synthesized from an estrone derivative by addition of organometallic reagents prepared from protected alpha,omega-alkynols and further elaboration of the addition products. The estrogenic activity of these novel compounds was determined using in vitro binding competition assay and transactivation analysis. Among the E2 derivatives synthesized, compound 2 showed the highest transactivation potency and was therefore tested for its ability to modulate cutaneous wound healing in vivo. Compound 2s ability to accelerate wound healing in ovariectomized mice and decrease the production of inflammatory molecules was comparable to that of E2. However, the activity of compound 2 was not superimposable to E2 with regard to the cells involved in the wound repairing process. When locally administered, compound 2 did not show any systemic activity on ER. This class of compounds with clear beneficial effects on wound healing and suitable for topical administration may lead to the generation of innovative drugs for an area of unmet clinical need.


Journal of Liquid Chromatography & Related Technologies | 2003

Chiral HPLC Resolution of the Wieland–Miescher Ketone and Derivatives

Francesca Leonelli; Barbara Garofalo; Luisa Maria Migneco; Rinaldo Marini Bettolo; Francesca Colais; Massimo Sinibaldi

Abstract The direct HPLC resolution of four structurally related compounds, the Wieland‐Miescher ketone, its C(5) homologue, and their C(1) dioxolane derivatives, was studied on commercially available polysaccharide‐based chiral stationary phases (CSPs) cellulose tris‐(3,5‐dimethylphenylcarbamate) (Chiralcel OD‐H), native β‐cyclodextrin (Cyclobond I), and acetylated, carboxymethylated and permethylated β‐cyclodextrins. The retention, resolution, and elution sequence of the enantiomeric couples were compared using different mobile phases. Baseline enantioseparation of all examined compounds was achieved only on the carboxymethyl‐derivatized β‐cyclodextrin stationary phase that appeared the most effective chiral selector for this class of compounds. Native, acetylated‐, and permethylated‐β‐cyclodextrin CSPs exhibited specific selectivity providing, in general, partial resolution of the compounds under investigation. On Chiralcel OD‐H, only two enantiomeric couples were fully separated. Elution orders depended on CSPs. To optimize chiral separation conditions, the influence of mobile phase composition on column retention and selectivity was also investigated.


Molecular Informatics | 2016

A Novel Multi-step Virtual Screening for the Identification of Human and Mouse mPGES-1 Inhibitors.

Gaia Corso; Maria Alessandra Alisi; Nicola Cazzolla; Isabella Coletta; Guido Furlotti; Barbara Garofalo; Giorgina Mangano; Francesca Mancini; Marco Vitiello; Rosella Ombrato

We present here the development of a novel virtual screening protocol combining Structure‐based and Ligand‐based drug design approaches for the identification of mouse mPGES‐1 inhibitors. We used the existing 3D structural data of the murine enzyme to hypothesize the inhibitors binding mode, which was the starting point for docking simulations, shape screening, and pharmacophore hypothesis screening. The protocol allowed the identification of 16 mouse mPGES‐1 inhibitors with low micromolar activity, which, notably, also inhibit the human enzyme in the same concentration range. The inhibitors predicted binding mode is expected to be the base for the rational drug design of new potent dual species inhibitors of human and murine mPGES‐1.


Organic Letters | 2002

Elusive 6-exo-Hydroxybicyclo[2.2.2]octan-2-ones from the Corresponding Acetates by Methanolysis in the Presence of CH3ONa/La(OTf)3

Stefano Di Stefano; Francesca Leonelli; Barbara Garofalo; Luigi Mandolini; Rinaldo Marini Bettolo; Luisa Maria Migneco


Tetrahedron | 2012

DPPH radical scavenging activity of paracetamol analogues

Maria Alessandra Alisi; Mario Brufani; Nicola Cazzolla; Francesca Ceccacci; Patrizia Dragone; M. Felici; Guido Furlotti; Barbara Garofalo; Angela La Bella; Osvaldo Lanzalunga; Francesca Leonelli; Rinaldo Marini Bettolo; Caterina Maugeri; Luisa Maria Migneco; Vincenzo Russo


Archive | 2009

1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40

Angelo Guglielmotti; Guido Furlotti; Giorgina Mangano; Nicola Cazzolla; Barbara Garofalo


Archive | 2007

2-arylindole derivatives as nPGES-1 inhibitors

Maria Alessandra Alisi; Nicola Cazzolla; Barbara Garofalo; Guido Furlotti; Caterina Maugeri; Rosella Ombrato; Isabella Coletta; Lorenzo Polenzani; Giorgina Mangano; Beatrice Garrone; Angelo Guglielmotti


Archive | 2009

1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1

Angelo Guglielmotti; Guido Furlotti; Giorgina Mangano; Nicola Cazzolla; Barbara Garofalo


Archive | 2009

3-AMINOCARBAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND PREPARATION METHOD THEREFOR

Maria Alessandra Alisi; Nicola Cazzolla; Isabella Coletta; Patrizia Dragone; Guido Furlotti; Barbara Garofalo; Angelo Guglielmotti; Giorgina Mangano; Caterina Maugeri


Magnetic Resonance in Chemistry | 2007

Spectroscopic characterization of 6-hydroxy and 1-methyl-6-hydroxybicyclo[2.2.2]octan-2-one ethylene acetals and ethylene dithioacetals

Francesca Leonelli; Barbara Garofalo; Angela La Bella; Ermanno Lasta; Francesca Ceccacci; Luisa Maria Migneco; Rinaldo Marini Bettolo

Collaboration


Dive into the Barbara Garofalo's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Angelo Guglielmotti

Mario Negri Institute for Pharmacological Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francesca Ceccacci

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Mario Brufani

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Francesca Leonelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Luigi Filocamo

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Roberta Joudioux

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge